AZELASTINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where AZELASTINE was used for Psoriasis.
Most Reported Side Effects for AZELASTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Treatment failure | 1,873 | 31.8% | 0 | 0 |
| Drug ineffective | 944 | 16.0% | 0 | 2 |
| No adverse event | 275 | 4.7% | 0 | 0 |
| Product delivery mechanism issue | 267 | 4.5% | 0 | 0 |
| Product dose omission issue | 259 | 4.4% | 0 | 0 |
| Dysgeusia | 246 | 4.2% | 0 | 2 |
| Headache | 205 | 3.5% | 0 | 10 |
| Nasal discomfort | 205 | 3.5% | 0 | 2 |
| Somnolence | 185 | 3.1% | 2 | 5 |
| Sneezing | 184 | 3.1% | 0 | 2 |
| Dizziness | 148 | 2.5% | 2 | 12 |
| Epistaxis | 130 | 2.2% | 0 | 4 |
| Fatigue | 114 | 1.9% | 0 | 14 |
| Dyspnoea | 113 | 1.9% | 3 | 13 |
| Nausea | 112 | 1.9% | 0 | 8 |
Other Indications for AZELASTINE
Product used for unknown indication (3,052)
Hypersensitivity (664)
Nasopharyngitis (453)
Rhinitis allergic (324)
Nasal congestion (176)
Conjunctivitis allergic (98)
Seasonal allergy (98)
Rhinorrhoea (89)
Sinusitis (86)
Sinus disorder (81)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)